‘Influence’ fears over CTP review

The tobacco industry has little faith that the upcoming external review of the Center for Tobacco Products (CTP) announced by US Food and Drug Administration (FDA) commissioner Robert Califf will help fix faults in the agency’s regulation of new tobacco and alternative products.

Industry representatives say the review, to be carried out by the agency’s partner organisation Reagan-Udall Foundation, is being launched at a time when delays and back-tracking in handling the pre-market tobacco application process (PMTA) for alternative tobacco products are all too evident and have already produced wide damage.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Corporate Email*

Company Name*

Name*

Department*

Industry*

Work Telephone*

How did you hear about us?*

Tell us what you're interested in*

Comments

This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Tiziana Cauli

Senior reporter/health & science editor

Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector. Tiziana holds a degree in Political Science and a PhD in African Studies from the University of Cagliari and she’s a graduate of the Carlo De Martino school of journalism in Milan.

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

LATEST ALERTS

Both sides fear undue influence on independent review of US FDA CTP

Tiziana Cauli

Our Key Benefits

Sign up to our newsletter

LATEST ALERTS

Want the full analysis? Let's talk

Tiziana Cauli

Our Key Benefits

Want the full analysis? Let's talk

Sign up to our newsletter

Start your FREE trial